Skip to NavigationSkip to content

Pharmafile - Medical Communications News

Exscientia has created a new OCD drug using artificial intelligence to sift through potential compounds, checking them against a huge database of...
Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got done – or at...
Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019, compared with 2018, while...
The FDA has made MDMA treatment for PTSD more accessible by putting it on its Expanded Access program.
Roche has released an update on the development of its immunology Tecentriq (atezolizumab), making it known that the drug failed to meet its...
14 people in the UK have been tested for the Chinese coronavirus, according to Public Health England (PHE).
A sales executive at the disgraced and bankrupted firm Insys who was accused of offering lap dances in order to persuade physicians to prescribe...
As fears rise over the impact and spread of Chinese coronavirus following news of a rising death toll and the first case occurring in US borders,...
Pakistan is cracking down on corruption and has registered cases against 200 pharmaceutical companies, while in the US the FDA has move to...
Japan’s Ministry of Health, Labour and Welfare (MHLW) has awarded marketing approval to ViiV Healthcare, a subsidiary of GSK, for its once-daily...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches